Chemkart India Ltd Q2 FY27 results deck summary

Results deck of 30 Oct 2026, summarised by AI from the filing.

Standalone EBITDA margin improved 150 bps and PAT margin 210 bps over H2 FY26.

Key takeaways

1. Standalone margin Standalone EBITDA margin improved 150 bps and PAT margin 210 bps over H2 FY26.
2. CDMO entry Construction of the EZRM SEZ nutraceutical CDMO facility at JNPT is in progress, aimed primarily at export markets.

Original filing on BSE

Chemkart India Ltd earnings call, investor presentation and press release summaries

• Q2 FY27: Results deck (30 Oct 2026)
• Q4 FY26: Results deck (18 May 2026)
• Q2 FY26: Results deck (12 Nov 2025)
• Other events: Strategy deck (11 Sep 2025)